Stanley Erck, CEO of Novavax, has said numbers show 'dramatic demonstrations' of the new vaccine's ability to develop an immune response against different strains of Covid-19.
The UK vaccines taskforce has bought 60m doses of the Novavax vaccine which will be manufactured on Teesside in the UK
- Novavax Covid vaccine shown to be nearly 90% effective in UK trial
- Coronavirus – latest updates
- See all our coronavirus coverage